SEC Form 4 · accession 0001104659-18-042301

Aptinyx Inc. · APTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Medical Officer

Period of report

Jun 25, 2018

Accepted (ET)

Jun 26, 2018 · 4:47 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001674365

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jun 25, 2018	C	2,328	—	A	226,089	D
Common Stock^F1	Jun 25, 2018	C	2,660	—	A	228,749	D
Common Stock^F1	Jun 25, 2018	C	1,801	—	A	230,550	D
Common Stock^F2	Jun 25, 2018	P	1,000	$16.00	A	231,550	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Series A-1 Convertible Preferred Stock^F1	—	Jun 25, 2018	C	64,212	D	—	—	Common Stock	2,328	D
Series A-2 Convertible Preferred Stock^F1	—	Jun 25, 2018	C	73,384	D	—	—	Common Stock	2,660	D
Series B Convertible Preferred Stock^F1	—	Jun 25, 2018	C	49,702	D	—	—	Common Stock	1,801	D

F1Each share of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 27.58621-for-one basis immediately prior to the closing of the Issuer's initial public offering without payment or consideration. The shares of Series A-1 Convertible Preferred Stock, Series A-2 Convertible Preferred Stock and Series B Convertible Preferred Stock had no expiration date.
F2On June 25, 2018, the Reporting Person purchased 1,000 shares of common stock of the Issuer at a price of $16.00 per share pursuant to an underwritten public offering.